Core Laboratories (CLB) Tops Q1 EPS by 2c, Offers Guidance

Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.08, $0.02 better than the analyst estimate of $0.06. Revenue for the quarter came in at $115.3 million versus the consensus estimate of $107.8 million.

GUIDANCE:

Core Laboratories sees Q2 2022 EPS of $0.12-$0.16, versus the consensus of $0.13. Core Laboratories sees Q2 2022 revenue of $119-125 million, versus the consensus of $114.3 million.

For earnings history and earnings-related data on Core Laboratories (CLB) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral